Key result
Machine learning models using routine clinical data identified patients at risk of failing to achieve HbA1c control with 73% precision among those in the top risk quartile.
Why the study?
Many patients at risk of CVD fail to control CVD risk factors, but clinicians lack a structured approach to identify them.
Can a machine learning model accurately predict the failure to achieve cardiovascular disease risk factor control in individuals with diabetes?
Observational (n=1,502)
Yes
Can a machine learning model accurately predict the failure to achieve cardiovascular disease risk factor control in individuals with diabetes?
Answers are grounded in this paper and cite their sources.
Machine learning models using routine clinical data can identify patients with diabetes at high risk of failing to achieve CVD risk factor control, enabling targeted interventions in resource-constrained settings.
A substantial share of patients at risk of developing cardiovascular disease (CVD) fail to achieve control of CVD risk factors, but clinicians lack a structured approach to identify these patients. We applied machine learning to longitudinal data from two completed randomized controlled trials among 1502 individuals with diabetes in urban India and Pakistan. Using commonly available clinical data, we predict each individual's risk of failing to achieve CVD risk factor control goals or meaningful improvements in risk factors at one year after baseline. When classifying those in the top quartile of predicted risk scores as at risk of failing to achieve goals or meaningful improvements, the precision for not achieving goals was 73% for HbA1c, 30% for SBP, and 24% for LDL, and for not achieving meaningful improvements 88% for HbA1c, 87% for SBP, and 85% for LDL. Such models could be integrated into routine care and enable efficient and targeted delivery of health resources in resource-constrained settings.
No takes yet. Share an insight, caveat, or question.
Reuter et al. (2024) conducted an observational in Type 2 diabetes with poor cardiometabolic control (n=1,502). Machine learning risk prediction models vs. Observed clinical outcomes was evaluated on Precision for predicting failure to achieve HbA1c control (HbA1c ≥ 8%) at 12 months among the top 25% of predicted risk scores (73% precision, 95% CI 64%-82%). Machine learning models using routine clinical data identified patients at risk of failing to achieve HbA1c control with 73% precision among those in the top risk quartile.
Synapse has enriched 10 related papers. Consider them for comparative context: